Conduit Pharmaceuticals Inc.
13F holders, Q3 2024 (September 30)At the end of Q3 2024, 35 institutions reported holding Conduit Pharmaceuticals Inc. in their 13F filings, up 6 from Q2 2024. 11 opened new positions and 6 sold out. The largest holders were Barclays PLC ($99K), BlackRock, Inc. ($90K) and Geode Capital Management, LLC ($51K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Cliff Asness (0.0% of AQR Capital Management's portfolio).
- Company
- Conduit Pharmaceuticals Inc.
- CUSIP
- 20678X106
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 11 | $83K |
| Exits | 6 | $203K |
All 13F filers, Q2 2024 → Q3 2024: 1,285,889 shares bought and 225,673 shares sold, net +1,060,216 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 35 holders
| Barclays PLC | 0.00% | Add +3.1% | 837,827 | $99K |
| BlackRock, Inc. | 0.00% | — | 755,613 | $90K |
| Geode Capital Management, LLC | 0.00% | Add +4.5% | 427,677 | $51K |
| Vanguard Group Inc. | 0.00% | Add +5.9% | 361,711 | $43K |
| Qube Research & Technologies Ltd | 0.00% | New | 318,359 | $38K |
| Citadel Advisors | 0.00% | New | 189,990 | $23K |
| Northern Trust Corp. | 0.00% | Add +520.1% | 184,837 | $22K |
| Morgan Stanley | 0.00% | Add +223.6% | 183,579 | $22K |
| UBS Group AG | 0.00% | Add +873.6% | 168,594 | $20K |
| New York State Common Retirement Fund | 0.00% | Reduce -9.6% | 88,700 | $11K |
| State Street Corp. | 0.00% | Add +2.4% | 86,849 | $10K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 53,111 | $6K |
| Goldman Sachs Group Inc. | 0.00% | Add +152.6% | 50,715 | $6K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 44,317 | $5K |
| SG Americas Securities, LLC | 0.00% | New | 40,894 | $5K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +204.4% | 37,151 | $4K |
| AQR Capital Management | 0.00% | New | 33,100 | $4K |
| XTX Topco Ltd | 0.00% | New | 24,854 | $3K |
| JPMorgan Chase & Co. | 0.00% | Add +122.7% | 21,875 | $3K |
| FMR LLC | 0.00% | New | 20,336 | $2K |
| Rhumbline Advisers | 0.00% | Reduce -16.2% | 20,037 | $2K |
| Susquehanna International Group, LLP | 0.00% | New | 18,179 | $2K |
| Bank of America Corp. | 0.00% | Add +56.2% | 17,910 | $2K |
| Citigroup Inc. | 0.00% | Add +208.4% | 16,686 | $2K |
| Corebridge Financial, Inc. | 0.00% | Reduce -0.6% | 12,323 | $1K |
| Invesco Ltd. | 0.00% | Reduce -77.7% | 10,757 | $1K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | New | 8,534 | $1K |
| Wells Fargo & Company | 0.00% | Add +0.1% | 8,470 | $1K |
| Ameritas Investment Partners, Inc. | 0.00% | No change | 2,258 | $268 |
| California State Teachers Retirement System | 0.00% | No change | 1,670 | $198 |
| Nisa Investment Advisors, LLC | 0.00% | New | 218 | $26 |
| Sterling Capital Management LLC | 0.00% | — | 44 | $5 |
| Amalgamated Bank | 0.00% | No change | 797 | $0 |
| Royal Bank of Canada | 0.00% | Add +24.6% | 2,702 | $0 |
| Cwm, LLC | 0.00% | New | 1,907 | $0 |
"% of holder's portfolio" is CONDUIT PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Conduit Pharmaceuticals Inc. the manager owns.